The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Negasheva E.S.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology;
The Russian National Research Medical University named after N.I. Pirogov

Frigo N.V.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Gushchin A.E.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Senina M.E.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Dolya O.V.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology;
Peoples’ Friendship University of Russia

Polevshchikova S.A.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Urogenital chlamydia infection. Bacterial load of causative agent and features of infection clinical course

Authors:

Negasheva E.S., Potekaev N.N., Frigo N.V., Gushchin A.E., Senina M.E., Dolya O.V., Polevshchikova S.A.

More about the authors

Read: 3098 times


To cite this article:

Negasheva ES, Potekaev NN, Frigo NV, Gushchin AE, Senina ME, Dolya OV, Polevshchikova SA. Urogenital chlamydia infection. Bacterial load of causative agent and features of infection clinical course. Russian Journal of Clinical Dermatology and Venereology. 2023;22(3):252‑259. (In Russ.)
https://doi.org/10.17116/klinderma202322031252

Recommended articles:
M. geni­talium-infection. Correlation between pathogen’s DNA concentration and clinical picture of disease. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):446-452
Epidemiological and socio-behavioral risk factors asso­ciated with transmission of lymphogranuloma vene­reum. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(6):742-748
Effe­ctiveness of biological mate­rial self-collection in men for diagnosis of sexually transmitted infe­ctions. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(6):790-797

References:

  1. Soetens LC, Koedijk FDH, van den Broek IVF, Vriend HJ, Op de Coul ELM, van Sighem AI, et al. Sexually transmittted infections including HIV in the Netherlands in 2012. Bilthoven: National Institute for Public Health and the Environment; 2013.
  2. Bender N, Herrmann B, Andersen B, Hocking JS, van Bergen J, Morgan J, et al. Chlamydia infection, pelvic inflammatory disease, ectopic pregnancy and infertility: cross-national study. Sexually transmitted infections. 2011;87(7):601-608. PMID: 22028428. Epub 2011/10/27. eng.  https://doi.org/10.1136/sextrans-2011-050205
  3. European Centre for Disease Prevention and Control. Introduction to the Annual Epidemiological Report. In: ECDC. Annual epidemiological report for 2018 [Internet]. Stockholm: ECDC; 2020 [cited 23 January 2020]. Accessed Mar 30, 2023. https://ecdc.europa.eu/annual-epidemiological-reports/methods;https://www.ecdc.europa.eu/sites/default/files/documents/AER-for-2018-STI-chlamydia.pdf
  4. Gotz H, Lindback J, Ripa T, Arneborn M, Ramsted K, Ekdahl K. Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods? Scandinavian journal of infectious diseases. 2002;34(1):28-34. PMID: 11874161. Epub 2002/03/05. eng. 
  5. Low N. Screening programmes for chlamydial infection: when will we ever learn? BMJ. 2007;334(7596):725-728. PMID: 17413173. Pubmed Central PMCID: 1847869.
  6. Land JA, Van Bergen JE, Morre SA, Postma MJ. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Human reproduction update. 2010;16(2):189-204. PMID: 19828674. https://doi.org/10.1093/humupd/dmp035
  7. Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. The Journal of infectious diseases. 2005;192(10):1836-1844. PMID: 16235186.
  8. CDC. Centers for Disease Control and Prevention [Electronic resource] Accessed Aug 31, 2022. https://www.cdc.gov/std/statistics/2020/figures.htm
  9. Kotova EG, Kobyakova OS, Starodubov VI, Aleksandrova GA, Bogdanova EV, Golubev NA, Melekhina LE, Ogryzko EV, Polikarpov AV i dr. Resursy i deyatel’nost’ medicinskih organizacij dermatovenerologichskogo profilya. Zabolevaemost’ infekciyami, peredavaemymi polovym putem, zaraznymi kozhnymi boleznyami i zabolevaniyami kozhi: statisticheskie materialy. M.: CNIIOIZ Minzdrava Rossii; 2021. (In Russ.).
  10. Aghaizu A, Reid F, Kerry S, Hay PE, Mallinson H, Jensen JS, et al. Frequency and risk factors for incident and redetected Chlamydia trachomatis infection Kong and Hocking BMC Infectious Diseases (2015) 15:293 Page 5 of 7 in sexually active, young, multi-ethnic women: a community based cohort study. Sex Transm Infect. 2014;90(7):524-528. 
  11. LaMontagne D, Baster K, Emmett L, Nichols T, Randall S, McLean L, et al. Incidence and reinfection rates of genital chlamydia infection among women aged 16 to 24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the chlamydia recall study advisory group. Sex Transm Infect. 2007;83(4):292-303. 
  12. Walker J, Tabrizi SN, Fairley CK, Chen MY, Bradshaw CS, Twin J, et al. Chlamydia trachomatis incidence and re-Infection among young women — behavioural and microbiological characteristics. PLoS One. 2012;7(5):e37778.
  13. Fung M, Scott KC, Kent CK, Klausner JD. Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. Sex Transm Infect. 2007;83(4):304-309. 
  14. Khosropour CM, Dombrowski JC, Barbee LA, Manhart LE, Golden MR. Comparing azithromycin and doxycycline for the treatment of rectal Chlamydial Infection: a retrospective cohort study. Sex Transm Dis. 2014;41(2): 79-85. 
  15. Renault CA, Israelski DM, Levy V, Fujikawa BK, Kellogg TA, Klausner JD. Timeto clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection. Sex Health. 2011;8(1):69-73. 
  16. Geisler WM, Suchland RJ, Whittington WL, Stamm WE. Quantitative culture of Chlamydia trachomatis: relationship of inclusion‐forming units produced in culture to clinical manifestations and acute inflammation in urogenital disease. J Infect Dis. 2001;184:1350‐1354.
  17. Michel C‐EC, Sonnex C, Carne CA, et al. Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies. J Clin Microbiol. 2007;45:1395‐1402.
  18. Agrawal T, Vats V, Salhan S, Mittal A. Determination of chlamydial load and immune parameters in asymptomatic, symptomatic and infertile women. FEMS Immun Med Micro. 2009;55:250‐257. 
  19. Jalal H, Verlander NQ, Kumar N, Bentley N, Carne C, Sonnex C. Genital chlamydial infection: association between clinical features, organism genotype and load. J Med Microbiol. 2011;60:881‐888. 
  20. Wiggins R, Graf S, Low N, Horner PJ. Real‐time quantitative PCR to determine chlamydial load in men and women in a community setting. J Clin Microbiol. 2009;47:1824‐1829.
  21. Janssen KJH, Wolffs PFG, Hoebe CJPA, Heijman T, Götz HM, Bruisten SM, Schim van der Loeff M, de Vries HJ, Dukers-Muijrers NHTM.Janssen KJH, et al. Determinants associated with viable genital or rectal chlamydia trachomatis bacterial load (FemCure). Sex Transm Infect. 2022;98(1):17-22.  https://doi.org/10.1136/sextrans-2020-054533
  22. Horner P. The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection. Sex Transm Infect. 2006;82(4):340-343.  https://doi.org/10.1136/sti.2005.019158
  23. van Rooijen MS, van der Loeff MF, Morre SA, et al. Spontaneous pharyngeal Chlamydia trachomatis RNA clearance. A cross-sectional study followed by a cohort study of untreated STI clinic patients in Amsterdam, The Netherlands. Sexually transmitted infections. 2015;91(3):157-164.  https://doi.org/10.1136/sextrans-2014-051633
  24. Kong FY, Tabrizi SN, Fairley CK, Phillips S, Fehler G, Law M, Vodstrcil LA, Chen M, Bradshaw CS, Hocking JS. Higher organism load associated with failure of azithromycin to treat rectal chlamydia. Epidemiol Infect. 2016;144(12):2587-2596. https://doi.org/10.1017/S0950268816000996
  25. em>Analiz chetyrekhpol’nyh tablic sopryazhennosti (sravnenie procentnyh dolej v dvuh gruppah) (onlajn kal’kulyator); kal’kulyator Hi-kvadrat, kriteriya Fishera, otnosheniya riskov [Elektronnyj resurs] https://medstatistic.ru/calculators/calchi.htmlhttps://molbiol.kirov.ru/utilites/multitool/
  26. Stephens RS. The cellular paradigm of chlamydial pathogenesis. Trends in microbiology. 2003;11(1):44-51. PMID: 12526854. Epub 2003/01/16. eng. 
  27. Rasmussen SJ. Chlamydia immunology. Current opinion in infectious diseases. 1998;11(1):37-41. PMID: 17033365. Epub 2006/10/13. eng. 
  28. Hryanin AA. The frequency of detection of chlamydia and gonococcal infections and features of sexual behavior in women of reproductive age. Medicinskij covet. 2014;9:106-109. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.